Rigenerand's Unattributed VC Round

Rigenerand raised a round of funding on May 11, 2016. Investors include Principia SGR.

Rigenerand owns proprietary technology to develop and produce biomedical tools to empower the ex-vivo phase of stem cells expansion combining the need of high cell yield with innovative biocompatible …

Articles about Rigenerand's Unattributed VC Round: